Equivalent 10-Year Outcomes After Implantation of Autologous Bone Marrow–Derived Mesenchymal Stem Cells Versus Autologous Chondrocyte Implantation for Chondral Defects of the Knee

Abstract

Background:

The use of bone marrow–derived mesenchymal stem cells (BMSCs) in cartilage repair procedures circumvents some of the limitations of autologous chondrocyte implantation (ACI), but long-term outcomes for this newer procedure are lacking. The authors previously reported comparable outcomes for the 2 procedures at 2-year follow-up.

Purpose/Hypothesis:

The purpose was to compare the long-term clinical outcomes of ACI versus BMSCs. It was hypothesized that there would be no significant difference between the groups in terms of patient-reported outcome scores and safety outcomes at 10-year follow-up.

Study Design:

Cohort study; Level of evidence, 2.

Methods:

Seventy-two patients who underwent either ACI or BMSC implantation—matched in terms of age and lesion site— were followed up to a median of at least 10 years. Patients were assessed with the 36-item Short Form Health Survey (SF-36), the International Knee Documentation Committee knee evaluation form, the Lysholm Knee Score, and the Tegner Activity Scale. In addition, information was obtained regarding any additional surgical procedures as well as safety data, with particular attention to infection and tumor formation.

Results:

There was an improvement in all patient-reported outcomes scores apart from the Mental Component Summary of the SF-36 after cartilage repair surgery. There was no significant difference in any of the patient-reported outcomes between cohorts at any time point. Six and 5 patients in the ACI and BMSC groups, respectively, underwent subsequent surgical procedures, including 1 total knee replacement in the BMSC group. None of the patients in either group developed any deep infection or tumor within the follow-up period.

Conclusion:

BMSC implantation used for the treatment of chondral defects of the knee appears to result in equivalent clinical outcomes to first-generation ACI at up to 10 years, with no apparent increased tumor formation risk.

Keywords

autologous chondrocyte implantation bone marrow–derived stem cells knee articular cartilage articular cartilage resurfacing

Get full access to this article

View all access options for this article.

References

Biant

Bentley

Vijayan

Skinner

Carrington

. Long-term results of autologous chondrocyte implantation in the knee for chronic chondral and osteochondral defects. Am J Sports Med. 2014;42(9):2178-2183.

Casiraghi

Remuzzi

Abbate

Perico

. Multipotent mesenchymal stromal cell therapy and risk of malignancies. Stem Cell Rev. 2013;9(1):65-79.

Chahla

Piuzzi

Mitchell

et al. Intra-articular cellular therapy for osteoarthritis and focal cartilage defects of the knee: a systematic review of the literature and study quality analysis. J Bone Joint Surg Am. 2016;98(18):1511-1521.

Clifford

Fisher

Brunskill

et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2012;2:CD006536.

Davatchi

Sadeghi Abdollahi

Mohyeddin

Nikbin

. Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients. Int J Rheum Dis. 2016;19(3):219-225.

DiBartola

Everhart

Magnussen

et al. Correlation between histological outcome and surgical cartilage repair technique in the knee: a meta-analysis. Knee. 2016;23(3):344-349.

Dindo

Demartines

Clavien

P-A

. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205.

Ding

Cicuttini

Jones

. Tibial subchondral bone size and knee cartilage defects: relevance to knee osteoarthritis. Osteoarthritis Cartilage. 2007;15(5):479-486.

Dozin

Malpeli

Camardella

Cancedda

Pietrangelo

. Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects. Matrix Biol. 2002;21(5):449-459.

10.

Dugard

Kuiper

Parker

et al. Development of a tool to predict outcome of autologous chondrocyte implantation. Cartilage. 2017;8(2):119-130.

11.

Ebert

Smith

Wood

Ackland

. A comparison of the responsiveness of 4 commonly used patient-reported outcome instruments at 5 years after matrix-induced autologous chondrocyte implantation. Am J Sports Med. 2013;41(12):2791-2799.

12.

Fahy

Alini

Stoddart

. Mechanical stimulation of mesenchymal stem cells: implications for cartilage tissue engineering. J Orthop Res. 2018;36(1):52-63.

13.

Greco

Anderson

Mann

et al. Responsiveness of the International Knee Documentation Committee subjective knee form in comparison to the Western Ontario and McMaster Universities Osteoarthritis Index, modified Cincinnati Knee Rating System, and Short Form 36 in patients with focal articular cartilage defects. Am J Sports Med. 2010;38(5):891-902.

14.

Heijink

Gomoll

Madry

et al. Biomechanical considerations in the pathogenesis of osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2012;20(3):423-435.

15.

Heir

Nerhus

Røtterud

et al. Focal cartilage defects in the knee impair quality of life as much as severe osteoarthritis: a comparison of knee injury and osteoarthritis outcome score in 4 patient categories scheduled for knee surgery. Am J Sports Med. 2010;38(2):231-237.

16.

Houghton

Stoicov

Nomura

et al. Gastric cancer originating from bone marrow–derived cells. Science. 2004;306(5701):1568-1571.

17.

Hunter

Schofield

Callander

. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol. 2014;10(7):437-441.

18.

Hunter

. Of the structure and diseases of articular cartilages. Philosophical Transactions of the Royal Society. 1744;42:514-521.

19.

Jiang

Jahagirdar

Reinhardt

et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418(6893):41.

20.

Keeney

Eunice

Pashos

Wright

Clohisy

. What is the evidence for total knee arthroplasty in young patients? A systematic review of the literature. Clin Orthop Relat Res. 2011;469(2):574-583.

21.

Kreuz

Müller

Erggelet

et al. Is gender influencing the biomechanical results after autologous chondrocyte implantation? Knee Surg Sports Traumatol Arthrosc. 2014;22(1):72-79.

22.

Kreuz

Müller

von Keudell

et al. Influence of sex on the outcome of autologous chondrocyte implantation in chondral defects of the knee. Am J Sports Med. 2013;41(7):1541-1548.

23.

Martin

Buckwalter

. The role of chondrocyte senescence in the pathogenesis of osteoarthritis and in limiting cartilage repair. J Bone Joint Surg Am. 2003;85(suppl 2):106-110.

24.

Nejadnik

Hui

Feng Choong

Tai

B-C

Lee

. Autologous bone marrow–derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med. 2010;38(6):1110-1116.

25.

Ogura

Mosier

Bryant

Minas

. A 20-year follow-up after first-generation autologous chondrocyte implantation. Am J Sports Med. 2017;45(12):2751-2761.

26.

Pareek

Carey

Reardon

Peterson

Stuart

Krych

. Long-term outcomes after autologous chondrocyte implantation: a systematic review at mean follow-up of 11.4 years. Cartilage. 2016;7(4):298-308.

27.

Peeters

Leijs

Reijman

van Osch

Bos

. Safety of intra-articular cell-therapy with culture-expanded stem cells in humans: a systematic literature review. Osteoarthritis Cartilage. 2013;21(10):1465-1473.

28.

Peng

Xie

Lin

et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology. 2011;54(3):820-828.

29.

Peterson

Vasiliadis

Brittberg

Lindahl

. Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med. 2010;38(6):1117-1124.

30.

Pittenger

Mackay

Beck

et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147.

31.

Røsland

Svendsen

Torsvik

et al. Long-term cultures of bone marrow–derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 2009;69(13):5331-5339.

32.

Rubio

Garcia-Castro

Martin

et al. Spontaneous human adult stem cell transformation. Cancer Res. 2005;65(8):3035-3039.

33.

Soler

Orozco

Munar

et al. Final results of a phase I-II trial using ex vivo expanded autologous mesenchymal stromal cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration. Knee. 2016;23(4):647-654.

34.

Spaeth

Klopp

Dembinski

Andreeff

Marini

. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 2008;15(10):730-738.

35.

Steadman

Briggs

Rodrigo

Kocher

Gill

Rodkey

. Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. Arthroscopy. 2003;19(5):477-484.

36.

Torsvik

Røsland

Svendsen

et al. Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track—letter. Cancer Res. 2010;70(15):6393-6396.

37.

Wakitani

Okabe

Horibe

et al. Safety of autologous bone marrow–derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med. 2011;5(2):146-150.

38.

Yamasaki

Mera

Itokazu

Hashimoto

Wakitani

. Cartilage repair with autologous bone marrow mesenchymal stem cell transplantation: review of preclinical and clinical studies. Cartilage. 2014;5(4):196-202.

39.

Yoo

Barthel

Nishimura

et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am. 1998;80(12):1745-1757.